| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |